Steven Cohen Haemonetics Corp Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Haemonetics Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 219,024 shares of HAE stock, worth $19 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
219,024
Previous 219,024
-0.0%
Holding current value
$19 Million
Previous $18.1 Million
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding HAE
# of Institutions
335Shares Held
55.8MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$598 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$516 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$445 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$332 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$332 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.44B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...